Toward evidence-based prescribing at end of life: A comparative review of temazepam and zolpidem for the treatment of insomnia

American Journal of Hospice and Palliative Medicine

Volumn 20, Issue 5, 2003, Pages 382-388

  Bain, Kevin T ^a   Weschules, Douglas J ^a   Knowlton, Calvin H ^a   Gallagher, Rollin ^a,b  

^a excelleRx Inc   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Insomnia; Palliative care; Sedatives; Sleep disorders; Temazepam; Zolpidem

Indexed keywords

BENZODIAZEPINE; TEMAZEPAM; ZOLPIDEM; ANXIOLYTIC AGENT; HYPNOTIC SEDATIVE AGENT; PYRIDINE DERIVATIVE;

CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CULTURAL ANTHROPOLOGY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HOSPICE CARE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MEDLINE; PRESCRIPTION; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SOCIAL ASPECT; TREATMENT WITHDRAWAL; ARTICLE; CLINICAL COMPETENCE; CLINICAL TRIAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DOSE RESPONSE; ECONOMICS; HEALTH CARE QUALITY; META ANALYSIS; RETROSPECTIVE STUDY; STANDARD; TIME;

ANTI-ANXIETY AGENTS; CLINICAL COMPETENCE; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HOSPICE CARE; HUMANS; HYPNOTICS AND SEDATIVES; PRESCRIPTIONS, DRUG; PYRIDINES; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES; SLEEP INITIATION AND MAINTENANCE DISORDERS; TEMAZEPAM; TIME FACTORS;

EID: 0642274552     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/104990910302000512     Document Type: Review

References (42)

1. Chokroverty S: Disorders of sleep. WebMD: Scientific American® Medicine [serial online]. October 2000 [cited December 31, 2002].
2. Marshall LL, Miller SW: Sleep disorders with aging. J Amer Soc Consultant Pharmacists [serial online. September 1996 11(Suppl 8) (23) [cited February 15 2002}. Available from URL: http://www.ascp.com/public/pubs/ cc/ supp8.shtml.
3. Mitler MM: Nonselective and selective benzodiazepine receptor agonists - Where are we today? Sleep. February 2000; 23(Suppl 1): 39-47.
4. Cramer GW, Chaponis RJ, Bauwens S et al.: Evaluation of sleep disorders in nursing facilities. Consult Pharm [serial online]. May 1999; 14: 545-556 [cited February 15, 2002]. Available from URL: http//www.ascp.com/ public/pubs/tcp/1999/may/r_r.shtml.
5. Vitiello MV: Sleep disorders and aging: Understanding the causes. J Gerontol Biol Sci Med Sci. 1997; 52(4): M189-191.
6. Monane M: Insommnia in the elderly. J Clin Psychiatr. June 1992; 53(Suppl): 23-28.
7. Dement WC, Miles LE, Carskadon MA: White Paper on sleep and aging. J Am Geriatr Soc. 1982; 30(1): 25-50.
8. Ancoli-Israel S: Sleep problems in older adults: Putting myths to bed. Geriatr. 1997; 52(1): 20-30.
9. Prinz PN, Vitiello MV, Raskind MA, et al: Geriatrics: Sleep disorders and aging. N Engl J Med. 1990; 323(8): 520-526.
10. Kupfer DJ, Reynolds CF: Management of insomnia. N Engl J Med. 1997; 336(5): 341-346.
11. Bootzin RR, Perlis ML: Nonpharmacologic treatments of insomnia. J Clin Psychiatr. June 1992; 53(Suppl 6): 37-41.
12. Spielman AJ, Saskin P, Thorpy MJ: Treatment of chronic insomnia by restriction of time in bed. Sleep. 1987; 10(1): 45-56.
13. Friedman L, Bliwise DL, Yesavage JA, et al: A preliminary study comparing sleep restriction and relaxation treatments for insomnia in older adults. J Gerontol. 1991; 46(1): 1-8.
14. Doghramji K, Fredman S: Sleepless in America - Diagnosing and treating insomnia. Medscape [serial online]. September 2000 [cited June 9, 2001]. Available from URL: http//www.medscape.com/viewprogram/ 347_pnt.
15. Avorn J, Soumerai SB: Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing." N Engl J Med. 1983; 308(24): 1457-1463.
16. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002; 288(23): 2981-2997.
17. Prosser H, Almond S, Walley T: Influences on GPs' decision to prescribe new drugs - The importance of who says what. Fam Pract. 2003; 20(1): 61-68.
18. Maczaj M: Pharmacologic treatment of insomnia. Drugs. 1993; 45(1): 44-45.
19. Mullan E, Katona C, Bellew M: Patterns of sleep disorders and sedative hypnotic use in seniors. Drugs & Aging. 1994; 5(1): 49-58.
20. Prinz PN: Sleep and sleep disorders in older adults. J Clin Neurophysiol. 1995; 12(2): 139-146.
21. Wooten V: Sleep disorders in geriatric patients. Clin Geriatr Med. 1992; 8(2): 427-439.
22. Shaughnessy AF: Drug prescribing for the elderly. Fam Pract Recertification. 1995; 17(1): 62-73.
23. Chapron DJ: Drug disposition and response in the elderly. In Delafuente JC, Stewart RB (eds.): Therapeutics in the Elderly, 2nd Edition. Cincinnati, Ohio: Harvey Whitney Books, 1995, 190-211.
24. Noyes MA, Lucas DS, Stratton MA: Principles of geriatric pharmacotherapy. J Geriatr Drug Ther. 1996; 10(3): 5-35.
25. Holm KJ, Goa KL: Zolpidem: An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs. 2000; 59(4): 865-889.
26. Perrault G, Morel E, Sanger DJ, et al.: Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. Eur J Pharmacol. 1990; 187(3): 487-494.
27. Corser B, Mayleben D, Doghramji K, et al.: No next-day residual sedation four hours after middle-of-the-night treatment with zaleplon. Sleep. 2000; 23(Suppl 2): A309.
28. Monti JM, Alvariño F, Monti D: Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia. Sleep. 2000; 23: 1075-1084.
29. Palagini L, Campbell IG, Tan X, et al.: Independence of sleep EEG responses to GABAergic hypnotics: Biological implications. J Psych Res. 2000; 34(4-5): 293-300.
30. Karlsson MO, Schoemaker RC, Kemp B, et al: A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep. Clin Pharmacol Ther. 2000; 68(2): 175-188.
31. Erman M, Erwin C, Gengo F: Efficacy of zolpidem and temazepam in transient insomnia [abstract]. 9th Annual Meeting of the Sleep Research Society. Nashville, Tennessee, May 30, 1995.
32. Gengo FM, Cwudzinski DM, Manning E: Residual daytime effects of zolpidem, temazepam, and doxylamine in healthy volunteers [abstract]. 9th Annual Meeting of the Sleep Research Society; Nashville, Tennessee, May 30, 1995.
33. Griffiths RR: Zolpidem, triazolam, and temazepam: Behavioral and subject-rated effects in normal volunteers. J Clin Psychopharmacol. 1996; 16(2): 146-157.
34. Leppik IE, Roth-Schechter GB, Gray GW: Double-blind, placebo-controlled comparison of zolpidem, triazolam, and temazepam in elderly patients with insomnia. Drug Dev Res. March 1997; 40: 230-238.
35. Roger M, Attali P, Coquelin JP: Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia. Clin Ther. 1993; 15(1): 127-136.
36. Rush CR: Behavioral pharmacology of zolpidem relative to benzodiazepines: A review. Pharm Biochem and Behav. 1998; 61(3): 253-269.
37. Vermeeren A, O'Hanlon JF, Declerck AC: Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo. Acta Ther. 1995; 21(1): 47-64.
38. Fleming J, Moldofsky H, Walsh JK: Comparison of the residual effects and efficacy of short term zolpidem, flurazepam and placebo in patients with chronic insomnia. Clin Drug Invest. 1995; 9(6): 303-313.
39. Rosenberg J, Ahlstrøm F: Randomized, double blind trial of zolpidem 10 mg versus triazolam 0.25 mg for treatment of insomnia in general practice. Scand J Prim Health Care. 1994; 12(2): 88-92.
40. Silvestri R, Ferrillo F, Murri L: Rebound insomnia after abrupt discontinuation of hypnotic treatment: Double-blind randomized comparison of zolpidem versus triazolam. Hum Psychopharm. May-June 1996; 11: 225-233.
41. Nowell PD, Mazumdar S, Buysse DJ, et al.: Benzodiazepines and zolpidem for chronic insomnia: A meta-analysis of treatment efficacy. JAMA. 1997; 278 (24): 2170-2177.
42. Wang PS, Bohn RL, Glynn RJ, et al.: Zolpidem use and hip fractures in older people. J Am Geriatr Soc. 2001; 49 (12): 1685-1690.